Clearizyme
Natural health product licensed in Canada
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80038575
- Status
- Active licence
- Licence date
- 9 January 2013
- Revision date
- 11 May 2016
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| papaïne Source : Carica papaya, fruit | 60 mg | Not calculated |
| papaïne Source : Carica papaya, fruit | 360 FCC PU | Not calculated |
| Pancréatine Source : Sus scrofa - pancréas | 150 mg | Not calculated |
| Pancréatine Source : Sus scrofa - pancréas | 22,500 unité d¿activité amylase de la USP | Not calculated |
| Pancréatine Source : Sus scrofa - pancréas | 22,500 Unité d'activité protéase de la USP | Not calculated |
| Pancréatine Source : Sus scrofa - pancréas | 1,800 Unité d'activité lipase de la USP | Not calculated |
| Pancréatine Source : Sus scrofa - pancréas | 30,000 unités de trypsine de la USP | Not calculated |
| Pancréatine Source : Sus scrofa - pancréas | 7,500 Unité de chymotrypsine de la USP | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Mucolytic enzyme helps to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and throat infections. Helps reduce (relieve) postoperative cheek swelling and/or pain after dental surgery.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80038575
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging